Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02798185 · ClinicalTrials.gov registry record
The DIAGNOSE-CTE Research Project
A clinical trial, sponsored by Boston University.
- Completed
- Registry status
- 240
- Enrollment target
NCT02798185: Completed study, sponsored by Boston University.
NCT02798185 is a clinical trial that has completed, run by Boston University. The registered enrollment target is 240 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02798185 has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
This is a study to develop methods of diagnosing chronic traumatic encephalopathy (CTE) during life, as well as to examine possible risk factors for this neurodegenerative disease. One component of this study is the use of an investigational PET scan radio tracer to detect abnormal tau protein in the brain.
Primary Outcome
Subjects will undergo a Florbetapir Positron Emission Tomography (PET) scan. The Outcome Measurement for the Florbetapir PET Scan will be "elevated" or "not elevated"
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2016-08 |
| Est. Completion | 2023-11-15 |
What the finished NCT02798185 record still lists
NCT02798185 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02798185 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02798185 about?
NCT02798185 is a clinical study titled "The DIAGNOSE-CTE Research Project". This is a study to develop methods of diagnosing chronic traumatic encephalopathy (CTE) during life, as well as to examine possible risk factors for this neurodegenerative disease. One component of this study is the use of an investigational PET scan radio tracer to detect abnormal tau protein in th...
What is the current status of trial NCT02798185?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2016-08. Estimated completion is 2023-11-15.
Who is sponsoring clinical trial NCT02798185?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia